|
[1] BOSMAN FT,CARNEIRO F,HRUBAN RH,et al. WHO classification of tumors of the digestive system[M]. 4th ed. Lyon:International Agency for Research on Cancer,2010:92.
|
|
[2] SHIA J,TANG LH,WEISER MR,et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?[J]. Am J Surg Pathol,2008,32(5):719-731.
|
|
[3] BOSMAN FT,CARNEIRO F,HRUBAN RH,et al. WHO classification of tumors of the digestive system[M]. 4th ed. Lyon:International Agency for Research on Cancer,2010:14.
|
|
[4] HUANG SS,JAN YJ,CHENG SB,et al. Large cell neuroendocrine carcinoma of the ampulla of vater:Report of a case[J]. Surg Today,2006,36(11):1032-1035.
|
|
[5] EMORY RE Jr,EMORY TS,GOELLNER JR,et al. Neuroendocrine ampullary tumors:Spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type[J]. Surgery,1994,115(6):762-766.
|
|
[6] STOJSIC Z,BRASANAC D,BILANOVIC D,et al. Large-cell neuroendocrine carcinoma of the ampulla of Vater[J]. Med Oncol,2010,27(4):1144-1148.
|
|
[7] NASSAR H,ALBORES-SAAVEDRA J,KLIMSTRA DS. Highgrade neuroendocrine carcinoma of the ampulla of vater:A clinicopathologic and immunohistochemical analysis of 14 cases[J].Am J Surg Pathol,2005,29(5):588-594.
|
|
[8] PALAZZO L. Imaging and staging of bilio-pancreatic tumours:Role of endoscopic and intraductal ultrasonography and guided cytology[J]. Ann Oncol,1999,10(Suppl 4):25-27.
|
|
[9] CHEN CH,YANG CC,YEH YH,et al. Reappraisal of endosonography of ampullary tumors:Correlation with transabdominal sonography,CT,and MRI[J]. J Clin Ultrasound,2009,37(1):18-25.
|
|
[10] LLOYD RV,OSAMURA RY,KLOPPEL G,et al. WHO classification of tumours of tumours of endocrine organs[M]. Lyon:International Agency for Research on Cancer,2017:235.
|
|
[11] BOSMAN FT,CARNEIRO F,HRUBAN RH,et al. WHO classification of tumors of the digestive system[M]. 4th ed. Lyon:International Agency for Research on Cancer,2010:93.
|
|
[12] TRAVIS WD,BRAMBILLA E,BURKE AP,et al. WHO classification of tumours of the lung,pleura,thymus and heart[M]. Lyon:International Agency for Research on Cancer,2015:70.
|
|
[13] FANG C,WANG W,ZHANG Y,et al. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms:A multicenter study in South China[J].Chin J Cancer,2017,36(1):51.
|
|
[14] GARCIA-CARBONERO R,JIMENEZ-FONSECA P,TEULEA,et al. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs)2014[J]. Clin Transl Oncol,2014,16(12):1025-1034.
|
|
[15] LAPOINT RJ,BOURNE PA,WANG HL,et al. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung[J]. Appl Immunohistochem Mol Morphol,2007,15(4):401-406.
|
|
[16] ROSSI G,CAVAZZA A,MARCHIONI A,et al. Role of chemotherapy and the receptor tyrosine kinases KIT,PDGFRalpha,PDGFRbeta,and Met in large-cell neuroendocrine carcinoma of the lung[J]. J Clin Oncol,2005,23(34):8774-8785.
|
|
[17] GENC CG,FALCONI M,PARTELLI S,et al. Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67[J]. Ann Surg Oncol,2018,25(8):2467-2474.
|
|
[18] KIM HS,LEE HS,NAM KH,et al. p27 Loss is associated with poor prognosis in gastroenteropancreatic neuroendocrine tumors[J]. Cancer Res Treat,2014,46(4):383-392.
|
|
[19] KOZUKI T,FUJIMOTO N,UEOKA H,et al. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma[J]. J Cancer Res Clin Oncol,2005,131(3):147-151.
|
|
[20] OHARA G,SATOH H,KIKUCHI N,et al. A long-term survivor with pulmonary large-cell neuroendocrine carcinoma[J].Respir Med,2007,101(11):2425-2427.
|
DownLoad: